CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study

被引：9
|
作者：
Niu, Jiahua [1 ,2 ]
Qiu, Huiying [1 ,2 ]
Xiang, Fang [3 ]
Zhu, Lin [3 ]
Yang, Jun [1 ,2 ]
Huang, Chongmei [1 ,2 ]
Zhou, Kun [1 ,2 ]
Tong, Yin [1 ,2 ]
Cai, Yu [1 ,2 ]
Dong, Baoxia [1 ,2 ]
Lu, Yuan [3 ]
Sun, Xuedong [3 ]
Wan, Liping [1 ,2 ]
Ding, Xueying [2 ]
Wang, Haopeng [4 ]
Song, Xianmin [1 ,2 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Sch Med, Dept Hematol, Shanghai, Peoples R China
[2] Shanghai Sci & Technol Comm STCSM, Engn Technol Res Ctr Cell Therapy & Clin Translat, Shanghai, Peoples R China
[3] Hrain Biotechnol, Shanghai, Peoples R China
[4] Shanghai Tech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China
来源：
BLOOD CANCER JOURNAL | 2023年 / 13卷 / 01期
基金：
国家重点研发计划;
关键词：
THERAPY; CD19;
D O I：
10.1038/s41408-023-00813-x
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [41] CAR T cells targeting BAFF-R can overcome CD19 antigen loss in B cell malignancies
    Qin, Hong
    Dong, Zhenyuan
    Wang, Xiuli
    Cheng, Wesley A.
    Wen, Feng
    Xue, Weili
    Sun, Han
    Walter, Miriam
    Wei, Guowei
    Smith, D. Lynne
    Sun, Xiuhua
    Fei, Fan
    Xie, Jianming
    Panagopoulou, Theano I.
    Chen, Chun-Wei
    Song, Joo Y.
    Aldoss, Ibrahim
    Kayembe, Clarisse
    Sarno, Luisa
    Muschen, Markus
    Inghirami, Giorgio G.
    Forman, Stephen J.
    Kwak, Larry W.
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (511)
  • [42] Chimeric Antigen Receptor (CAR) T Cells: Lessons Learned from Targeting of CD19 in B-Cell Malignancies
    Hay, Kevin A.
    Turtle, Cameron J.
    DRUGS, 2017, 77 (03) : 237 - 245
  • [43] Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
    Paszkiewicz, Paulina J.
    Fraessle, Simon P.
    Srivastava, Shivani
    Sommermeyer, Daniel
    Hudecek, Michael
    Drexler, Ingo
    Sadelain, Michel
    Liu, Lingfeng
    Jensen, Michael C.
    Riddell, Stanley R.
    Busch, Dirk H.
    JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (11) : 4262 - 4272
  • [44] Manufacture of CD22 CAR T cells following positive versus negative selection results in distinct cytokine secretion profiles and yδ T cell output
    Song, Hannah W.
    Benzaoui, Mehdi
    Dwivedi, Alka
    Underwood, Sarah
    Shao, Lipei
    Achar, Sooraj
    Posarac, Vesna
    Remley, Victoria A.
    Prochazkova, Michaela
    Cai, Yihua
    Jin, Ping
    Somerville, Robert P.
    Stroncek, David F.
    Altan-Bonnet, Gregoire
    Shah, Nirali N.
    Chien, Christopher D.
    Taylor, Naomi
    Highfill, Steven L.
    MOLECULAR THERAPY METHODS & CLINICAL DEVELOPMENT, 2024, 32 (01)
  • [45] Treatment with anti CD19 chimeric antigen receptor T cells after antibody-based immunotherapy in adults with acute lymphoblastic leukemia
    Danylesko, Ivetta
    Chowers, Guy
    Shouval, Roni
    Besser, Michal J.
    Jacoby, Elad
    Shimoni, Avichai
    Nagler, Arnon
    Avigdor, Abraham
    CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2020, 68 (01) : 17 - 22
  • [46] How I use risk factors for success or failure of CD19 CAR T cells to guide management of children and AYA with B-cell ALL
    Myers, Regina M.
    Shah, Nirali N.
    Pulsipher, Michael A.
    BLOOD, 2023, 141 (11) : 1251 - 1264
  • [47] Cytotoxicity of CD56-positive lymphocytes against autologous B-cell precursor acute lymphoblastic leukemia cells
    Fei, F.
    Lim, M.
    George, A. A.
    Kirzner, J.
    Lee, D.
    Seeger, R.
    Groffen, J.
    Abdel-Azim, H.
    Heisterkamp, N.
    LEUKEMIA, 2015, 29 (04) : 788 - 797
  • [48] Impact of Consolidative Unrelated Cord Blood Transplantation on Clinical Outcomes of Patients With Relapsed/Refractory Acute B Lymphoblastic Leukemia Entering Remission Following CD19 Chimeric Antigen Receptor T Cells
    Xu, Qianwen
    Xue, Lei
    An, Furun
    Xu, Hui
    Wang, Li
    Geng, Liangquan
    Zhang, Xuhan
    Song, Kaidi
    Yao, Wen
    Wan, Xiang
    Tong, Juan
    Liu, Huilan
    Liu, Xin
    Zhu, Xiaoyu
    Zhai, Zhimin
    Sun, Zimin
    Wang, Xingbing
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [49] A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells
    Riillo, Caterina
    Caracciolo, Daniele
    Grillone, Katia
    Polera, Nicoletta
    Tuccillo, Franca Maria
    Bonelli, Patrizia
    Juli, Giada
    Ascrizzi, Serena
    Scionti, Francesca
    Arbitrio, Mariamena
    Lopreiato, Mariangela
    Siciliano, Maria Anna
    Sestito, Simona
    Talarico, Gabriella
    Galea, Eulalia
    Galati, Maria Concetta
    Pensabene, Licia
    Loprete, Giovanni
    Rossi, Marco
    Ballerini, Andrea
    Gentile, Massimo
    Britti, Domenico
    Di Martino, Maria Teresa
    Tagliaferri, Pierosandro
    Tassone, Pierfrancesco
    CANCERS, 2022, 14 (12)
  • [50] Hematopoietic Cell Transplantation after CD19 Chimeric Antigen Receptor T Cell-Induced Acute Lymphoblastic Leukemia Remission Confers a Leukemia-Free Survival Advantage
    Summers, Corinne
    Wu, Qian Vicky
    Annesley, Colleen
    Bleakley, Marie
    Dahlberg, Ann
    Narayanaswamy, Prabha
    Huang, Wenjun
    Voutsinas, Jenna
    Brand, Adam
    Leisenring, Wendy
    Jensen, Michael C.
    Park, Julie R.
    Gardner, Rebecca A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (01): : 21 - 29
12345